Advancement in New Drug Discovery for Treatment of Hepatitis

  • Sofosbuvir plus simeprevir for genotype 1 chronic hepatitis C infection
  • Sofosbuvir for genotype 2 and 3 chronic hepatitis C infection
  • Ribavirin for chronic hepatitis E infection in transplant recipients

Related Conference of Advancement in New Drug Discovery for Treatment of Hepatitis

December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
January 30-31, 2019 |

World Congress on Pancreatic Cancer and Liver Diseases

Radisson Hotel Narita | Tokyo, Japan
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
May 15-16, 2019

21st World Congress on Advances in Gastroenterology and Hepatology

Mercure Melbourne Albert Park, Melbourne, Australia
June 17-18, 2019

World Liver Conference 2019

Columbus, Ohio, U.S.A
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
September 23-24, 2019

World Summit on Liver Cirrhosis and Hepatitis

Tokyo, Japan
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Advancement in New Drug Discovery for Treatment of Hepatitis Conference Speakers